Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in the molecular mechanisms of NLRP3 inflammasome activators and inactivators
Dongling Liu, Xiang Zeng, Xiao Li, et al.
Biochemical Pharmacology (2020) Vol. 175, pp. 113863-113863
Closed Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

An update on the regulatory mechanisms of NLRP3 inflammasome activation
Seungwha Paik, Jin Kyung Kim, Prashanta Silwal, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 5, pp. 1141-1160
Open Access | Times Cited: 533
NLRP3 regulates alveolar bone loss in ligature‐induced periodontitis by promoting osteoclastic differentiation
Yuyi Chen, Qiudong Yang, C. Lv, et al.
Cell Proliferation (2020) Vol. 54, Iss. 2
Open Access | Times Cited: 118
The Nlrp3 inflammasome as a “rising star” in studies of normal and malignant hematopoiesis
Mariusz Z. Ratajczak, Kamila Bujko, Monika Cymer, et al.
Leukemia (2020) Vol. 34, Iss. 6, pp. 1512-1523
Open Access | Times Cited: 88
Proprotein Convertase Subtilisin/Kexin Type 9
Chiara Macchi, Nicola Ferri, Cesare R. Sirtori, et al.
American Journal Of Pathology (2021) Vol. 191, Iss. 8, pp. 1385-1397
Open Access | Times Cited: 86
The Role of NLRP3 Inflammasome in Cerebrovascular Diseases Pathology and Possible Therapeutic Targets
Rongrong Bai, Yue Lang, Jie Shao, et al.
ASN NEURO (2021) Vol. 13, pp. 175909142110181-175909142110181
Open Access | Times Cited: 61
Leptin Aggravates Periodontitis by Promoting M1 Polarization via NLRP3
Yineng Han, Yiping Huang, Pengfei Gao, et al.
Journal of Dental Research (2022) Vol. 101, Iss. 6, pp. 675-685
Closed Access | Times Cited: 53
Role of NLRP3 Inflammasome in Rheumatoid Arthritis
Hui Yin, Na Liu, Keshav Raj Sigdel, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 45
Recent advances in gout drugs
Cheng Shi, Ziting Zhou, Xiaowei Chi, et al.
European Journal of Medicinal Chemistry (2022) Vol. 245, pp. 114890-114890
Closed Access | Times Cited: 45
Alterations of the gut microbiota and metabolomics in children with e-waste lead exposure
Xiang Zeng, Zhijun Zeng, Qihua Wang, et al.
Journal of Hazardous Materials (2022) Vol. 434, pp. 128842-128842
Closed Access | Times Cited: 43
Total paeony glycoside relieves neuroinflammation to exert antidepressant effect via the interplay between NLRP3 inflammasome, pyroptosis and autophagy
Lili Su, Haoyu Lu, Dongxue Zhang, et al.
Phytomedicine (2024) Vol. 128, pp. 155519-155519
Closed Access | Times Cited: 11
Berberine Protects Against NLRP3 Inflammasome via Ameliorating Autophagic Impairment in MPTP-Induced Parkinson’s Disease Model
Shuxuan Huang, Hanqun Liu, Yuwan Lin, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 55
DExD/H-box helicases: multifunctional regulators in antiviral innate immunity
Chenhe Su, Yan-Dong Tang, Chunfu Zheng
Cellular and Molecular Life Sciences (2021) Vol. 79, Iss. 1
Open Access | Times Cited: 46
Astragaloside IV ameliorates diabetic nephropathy in db/db mice by inhibiting NLRP3 inflammasome‑mediated inflammation
Hui Feng, Xiaoyun Zhu, Yang Tang, et al.
International Journal of Molecular Medicine (2021) Vol. 48, Iss. 2
Open Access | Times Cited: 43
Recent Update on the Development of PCSK9 Inhibitors for Hypercholesterolemia Treatment
Shakir Ahamad, Shahnawaz Ali Bhat
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 23, pp. 15513-15539
Closed Access | Times Cited: 37
NLRP3-Mediated Inflammation in Atherosclerosis and Associated Therapeutics
Na Lu, Weijia Cheng, Dongling Liu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 31
The beneficial effects of astragaloside IV on ameliorating diabetic kidney disease
Yiwei Gao, Xin Su, Taiqi Xue, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114598-114598
Open Access | Times Cited: 22
Lycopene ameliorates DEHP exposure-induced renal pyroptosis through the Nrf2/Keap-1/NLRP3/Caspase-1 axis
Muzi Li, Yi Zhao, Xueyan Dai, et al.
The Journal of Nutritional Biochemistry (2023) Vol. 113, pp. 109266-109266
Closed Access | Times Cited: 20
NLRP3 inflammasome in cognitive impairment and pharmacological properties of its inhibitors
Yi Xu, Yanling Yang, Xi Chen, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 18
Caspase-1 has a critical role in blood-brain barrier injury and its inhibition contributes to multifaceted repair
Hila Israelov, Orly Ravid, Dana Atrakchi, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 45
The role of NLRP3 inflammasome in the pathogenesis of rheumatic disease
Ruixue Kong, Lulu Sun, Hua Li, et al.
Autoimmunity (2021) Vol. 55, Iss. 1, pp. 1-7
Closed Access | Times Cited: 35
Pyroptosis in NLRP3 inflammasome-related atherosclerosis
Xiang Zeng, Dongling Liu, Xia Huo, et al.
Cell Stress (2022) Vol. 6, Iss. 10, pp. 79-88
Open Access | Times Cited: 24
Cochlear Marginal Cell Pyroptosis Is Induced by Cisplatin via NLRP3 Inflammasome Activation
Wenting Yu, Shimin Zong, Peng Zhou, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
The Role of the NLRP3 Inflammasome in Mediating Glomerular and Tubular Injury in Diabetic Nephropathy
Bethany M. Williams, Chelsy L. Cliff, K. Lee, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 23
Modulation of NRF2: Biological Dualism in Cancer, Targets and Possible Therapeutic Applications
M. Gallorini, Simone Carradori, Emiliano Panieri, et al.
Antioxidants and Redox Signaling (2023) Vol. 40, Iss. 10-12, pp. 636-662
Closed Access | Times Cited: 16
Pharmacological targets at the lysosomal autophagy–NLRP3 inflammasome crossroads
Srinivasa Reddy Bonam, Dylan Mastrippolito, Philippe Georgel, et al.
Trends in Pharmacological Sciences (2023) Vol. 45, Iss. 1, pp. 81-101
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top